Evox Therapeutics

At Evox Therapeutics, we focus on tackling genetically defined CNS disorders using exosome-based genome-editing therapeutics. Our lead programs address SCA2/ALS targeting ATXN2 and Huntington’s disease targeting MSH3


Address

Oxford
Oxfordshire
United Kingdom
Loading